نتایج جستجو برای: protease inhibitor

تعداد نتایج: 245560  

A Shakoori F Kobarfard J Pourahmad

It has already been reported that muscle necrosis induced by various phenylenediamine derivatives are correlated with their autoxidation rate. Now in a more detailed investigation of the cytotoxic mechanism using a model system of isolated hepatocytes and ring-methylated structural isomer durenediamine (DD) we have shown that under aerobic conditions, phenylenediamine induced cytotoxicity and R...

Background: The hepatitis C virus (HCV) infection is a major global health problem and one of the common causes of mortality worldwide. Therefore, currently many studies have been focused on introducing novel and effective anti HCV agents especially plant materials. Therefore, the study was aimed to screening novel HCV protease inhibitor(s) from two medicinal plants including Cornus officinalis...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2011
Nikolaus Schiering Allan D'Arcy Frederic Villard Oliver Simic Marion Kamke Gaby Monnet Ulrich Hassiepen Dmitri I Svergun Ruth Pulfer Jörg Eder Prakash Raman Ursula Bodendorf

Hepatitis C virus (HCV) infection is a global health burden with over 170 million people infected worldwide. In a significant portion of patients chronic hepatitis C infection leads to serious liver diseases, including fibrosis, cirrhosis, and hepatocellular carcinoma. The HCV NS3 protein is essential for viral polyprotein processing and RNA replication and hence viral replication. It is compos...

Journal: :Journal of Molecular Docking 2021

SARS-CoV-2, a new type of Coronavirus, has affected more millions people worldwide. From the spread this infection, many studies related to virus and drug designing for treatment have been started. Most target SARS-CoV-2 main protease, spike protein SASR-CoV-2, some are targeting human furin protease. In current work, we chose clinically used molecules remdesivir, favipiravir, lopinavir, hydrox...

2014
David A Cooper

WHO standard of care for failure of a first regimen, usually 2N(t)RTI's and an NNRTI, consists of a ritonavir-boosted protease inhibitor with a change in N(t)RTI's. Until recently, there was no evidence to support these recommendations which were based on expert opinion. Two large randomized clinical trials, SECOND LINE and EARNEST both showed excellent response rates (>80%) for the WHO standar...

2011
Sander I. van Kasteren Ilana Berlin Jeff D. Colbert Doreen Keane Huib Ovaa Colin Watts

Proteases constitute a major class of drug targets. Endosomal compartments harbor several protease families whose attenuation may be beneficial to a number of biological processes, including inflammation, cancer metastasis, antigen presentation, and parasite clearance. As a step toward the goal of generalized but targeted protease inhibition in the endocytic pathway, we describe here the synthe...

زهرایی, مهین , خیرالله , علیرضا ,

Alpha-1- Protease inhibitor or a1-Antitrypsin (a1-AT) is an a1-glycoprotein and a small molecule which acts as an extracellular inhibitor of serin proteases. It seems that this molecule protein has a protective role in tissues such as inhibition (inactivation) of elastase, colagenase, etc. a1-AT deficiency is a hereditary disorder which characteristed by reduced a1-AT serum level and may ...

Journal: :Chembiochem : a European journal of chemical biology 2015
Julien Roche John M Louis Ad Bax

Flexibility of the glycine-rich flaps is known to be essential for catalytic activity of the HIV-1 protease, but their exact conformations at the different stages of the enzymatic pathway remain subject to much debate. Although hundreds of crystal structures of protease-inhibitor complexes have been solved, only about a dozen inhibitor-free protease structures have been reported. These latter s...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید